10-05-2017 дата публикации
Номер: KR1020170049216A
Принадлежит:
The present invention relates to a novel Lactobacillus gasseri strain and uses thereof. Provided are a Lactobacillus gasseri strain having probiotic activity deposited with accession number KCCM11777P; a pharmaceutical composition for the treatment or prevention of inflammatory diseases comprising, as an active ingredient, at least one selected from the group consisting of the strain, a lysate of the strain, a culture of the strain, a concentrate of the culture, a dried product of the culture and a fermented product by the strain; a food composition for the improvement or prevention of inflammatory diseases; and a probiotic composition. According to the present invention, the strain has excellent acid resistance, bile resistance and intestinal adherence, and induces an immune response by Th_2 cells to treat and alleviate an inflammatory disease caused by an excessive immune response of Th_1 cells with an inflammation mitigating effect through immunomodulation. COPYRIGHT KIPO 2017 ...
Подробнее